Patent Lifts Lid on Neonicotinoid Use in Salmon Farming

 

 

 

A patent filed in Canada (CA3045239A1) in December 2017 (published in June 2018 & described as a 'National Entry' in May 2019) lifts the lid on how Norwegian-owned Benchmark plans to use the toxic neonicotinoid insecticide Imidacloprid in salmon farming. 

 

Imidacloprid Canadian Patent CA3045239A1 #1

 

Imidacloprid Canadian Patent CA3045239A1 #2

Imidacloprid Canadian Patent CA3045239A1 #3

 

Imidacloprid Canadian Patent CA3045239A1 #4

 

Imidacloprid Canadian Patent CA3045239A1 #5

Imidacloprid Canadian Patent CA3045239A1 #6

 

The Canadian patent continued:

 

Imidacloprid Canadian Patent CA3045239A1 #7

Imidacloprid Canadian Patent CA3045239A1 #8

 

Imidacloprid Canadian Patent CA3045239A1 #9

 

Moreover:

 

Imidacloprid Canadian Patent CA3045239A1 #10

Imidacloprid Canadian Patent CA3045239A1 #11

 

And:

 

Imidacloprid Canadian Patent CA3045239A1 #12

 

And:

 

Imidacloprid Canadian Patent CA3045239A1 #13

 

Moreover:

 

Imidacloprid Canadian Patent CA3045239A1 #14

 

The Canadian patent provided examples of use including:

 

Imidacloprid Canadian Patent CA3045239A1 #15

Imidacloprid Canadian Patent CA3045239A1 #16

Imidacloprid Canadian Patent CA3045239A1 #17

 

The Canadian patent also detailed:

 

Imidacloprid Canadian Patent CA3045239A1 #18

 

And:

 

Imidacloprid Canadian Patent CA3045239A1 #19

 

Finally, the patent claims that Imidacloprid is safe for fish (contrary to other scientific evidence that Imidacloprid is toxic to fish):

 

Imidacloprid Canadian Patent CA3045239A1 #20

 

Download the 42 page patent in full online here

 

 

 

One of the 'inventors' of Imidacloprid use in salmon farming is Benchmark's John Marshall who, according to documents disclosed in December 2019 via FOI, has been lobbying the Scottish Government since at least September 2018 with a meeting in Edinburgh in October 2018 and a meeting in the Scottish Parliament with Fergus Ewing, Cabinet Secretary for Rural Economy & Connectivity, in September 2019. 

 

John Marshall bio #2 SP meeting with Fergus Sept 2018 John Marshall bio #3 SP meeting with Fergus Sept 2018

John Marshall bio #4 SP meeting with Fergus Sept 2018

 

John Marshall bio #1

John Marshall bio #5 SP meeting with Fergus Sept 2018

 

 

Earlier this month (8 June 2020), Scottish Salmon Watch revealed how Benchmark-owned Fish Vet Group (based in Inverness) filed a patent in Norway in 2011

 

Imidacloprid Norwegian Patent 2011

Imidacloprid Norwegian Patent 2011 in full

 

 

 

 

Read more via:

US Patent – Fish feed compositions containing a neonicotinoid for preventing and treating parasite infections

WO2015198247 – FISH FEED COMPOSITIONS CONTAINING A NEONICOTINOID FOR PREVENTING AND TREATING PARASITE INFECTIONS

Patent sought for neonicotinoid-based sea louse treatment

 

 

It seems Benchmark insiders may already know that BMK08/Ectosan (Imidacloprid) will be approved.   If so, Benchmark claimed in January 2020 "that the BMK08/CleanTreat solution could reach peak annual sales of £50 million in Norway alone and £75 million globally".   Fish Farming Expert reported in December 2017: "Benchmark believes that Ectosan can eventually achieve worldwide sales of £40-50 million annually".  Salmon Business reported (8 June 2020):

 

 

 

Read more via:

 

PR Scientific Opposition to Imidacloprid Use in Salmon Farming 8 June 2020 Tweet #2 Dave Goulson

Imidacloprid graphic Water bottle spoof

Imidacloprid graphic Will the Minister drink it

 

PR Scientific Opposition to Imidacloprid Use in Salmon Farming 8 June 2020 Tweet #6 bottle spoofs

 

 

Read more on Scottish Salmon Watch's smoking hot campaign against salmon farming online here

 

Gallery #5 online via Scottish Scamon

 

#10 Farmed Salmon Contains Cancer Causing Chemicals

 

Cigarette 29 Chemicals

 

PR Ectosan BMK08 17 March 2020 Tweet #1 10

 

 

 

Scroll to Top